Cardiac applications of 123I-mIBG imaging

Amala Chirumamilla, Mark I. Travin

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Cardiac autonomic innervation plays a key role in maintaining hemodynamic and electrophysiologic harmony. Cardiac sympathetic function is adversely altered in many disease states, such as congestive heart failure, myocardial ischemia, and diabetes. 123I-mIBG, a sympathetic neurotransmitter radionuclide analog, aids in the detection of sympathetic innervation abnormalities and can be imaged with planar and single-photon emission computed tomographic techniques. Cardiac 123I-mIBG uptake can be assessed by the heart mediastinal ratio (H/M), tracer washout rate, and focal uptake defects. These parameters have been widely studied and shown to correlate strongly and independently with congestive heart failure progression, cardiac arrhythmias, cardiac death, and all-cause mortality. There is accumulating evidence that 123I-mIBG imaging can help to monitor a patient's clinical course and response to therapy. The ability to predict potentially lethal ventricular arrhythmias promises to help more accurately select patients for implantable cardioverter defibrillators, limiting unnecessary devices and identifying additional patients at risk who do not meet current guidelines. 123I-mIBG shows potential to help determine whether greater risk and usually more expensive ventricular assist device therapies or cardiac transplantation might be needed. Although more investigation in larger populations is needed to strengthen previous findings, cardiac 123I-mIBG imaging shows promise as a new technique for recognizing and following potentially life-threatening cardiac conditions.

Original languageEnglish (US)
Pages (from-to)374-387
Number of pages14
JournalSeminars in Nuclear Medicine
Volume41
Issue number5
DOIs
StatePublished - Sep 2011

Fingerprint

Cardiac Arrhythmias
Heart Failure
Heart-Assist Devices
Implantable Defibrillators
Heart Transplantation
Photons
Radioisotopes
Myocardial Ischemia
Neurotransmitter Agents
Hemodynamics
Guidelines
Equipment and Supplies
Mortality
Therapeutics
Population

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Cardiac applications of 123I-mIBG imaging. / Chirumamilla, Amala; Travin, Mark I.

In: Seminars in Nuclear Medicine, Vol. 41, No. 5, 09.2011, p. 374-387.

Research output: Contribution to journalArticle

Chirumamilla, Amala ; Travin, Mark I. / Cardiac applications of 123I-mIBG imaging. In: Seminars in Nuclear Medicine. 2011 ; Vol. 41, No. 5. pp. 374-387.
@article{665cc39863084cf4aee0f702e40d0300,
title = "Cardiac applications of 123I-mIBG imaging",
abstract = "Cardiac autonomic innervation plays a key role in maintaining hemodynamic and electrophysiologic harmony. Cardiac sympathetic function is adversely altered in many disease states, such as congestive heart failure, myocardial ischemia, and diabetes. 123I-mIBG, a sympathetic neurotransmitter radionuclide analog, aids in the detection of sympathetic innervation abnormalities and can be imaged with planar and single-photon emission computed tomographic techniques. Cardiac 123I-mIBG uptake can be assessed by the heart mediastinal ratio (H/M), tracer washout rate, and focal uptake defects. These parameters have been widely studied and shown to correlate strongly and independently with congestive heart failure progression, cardiac arrhythmias, cardiac death, and all-cause mortality. There is accumulating evidence that 123I-mIBG imaging can help to monitor a patient's clinical course and response to therapy. The ability to predict potentially lethal ventricular arrhythmias promises to help more accurately select patients for implantable cardioverter defibrillators, limiting unnecessary devices and identifying additional patients at risk who do not meet current guidelines. 123I-mIBG shows potential to help determine whether greater risk and usually more expensive ventricular assist device therapies or cardiac transplantation might be needed. Although more investigation in larger populations is needed to strengthen previous findings, cardiac 123I-mIBG imaging shows promise as a new technique for recognizing and following potentially life-threatening cardiac conditions.",
author = "Amala Chirumamilla and Travin, {Mark I.}",
year = "2011",
month = "9",
doi = "10.1053/j.semnuclmed.2011.04.001",
language = "English (US)",
volume = "41",
pages = "374--387",
journal = "Seminars in Nuclear Medicine",
issn = "0001-2998",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Cardiac applications of 123I-mIBG imaging

AU - Chirumamilla, Amala

AU - Travin, Mark I.

PY - 2011/9

Y1 - 2011/9

N2 - Cardiac autonomic innervation plays a key role in maintaining hemodynamic and electrophysiologic harmony. Cardiac sympathetic function is adversely altered in many disease states, such as congestive heart failure, myocardial ischemia, and diabetes. 123I-mIBG, a sympathetic neurotransmitter radionuclide analog, aids in the detection of sympathetic innervation abnormalities and can be imaged with planar and single-photon emission computed tomographic techniques. Cardiac 123I-mIBG uptake can be assessed by the heart mediastinal ratio (H/M), tracer washout rate, and focal uptake defects. These parameters have been widely studied and shown to correlate strongly and independently with congestive heart failure progression, cardiac arrhythmias, cardiac death, and all-cause mortality. There is accumulating evidence that 123I-mIBG imaging can help to monitor a patient's clinical course and response to therapy. The ability to predict potentially lethal ventricular arrhythmias promises to help more accurately select patients for implantable cardioverter defibrillators, limiting unnecessary devices and identifying additional patients at risk who do not meet current guidelines. 123I-mIBG shows potential to help determine whether greater risk and usually more expensive ventricular assist device therapies or cardiac transplantation might be needed. Although more investigation in larger populations is needed to strengthen previous findings, cardiac 123I-mIBG imaging shows promise as a new technique for recognizing and following potentially life-threatening cardiac conditions.

AB - Cardiac autonomic innervation plays a key role in maintaining hemodynamic and electrophysiologic harmony. Cardiac sympathetic function is adversely altered in many disease states, such as congestive heart failure, myocardial ischemia, and diabetes. 123I-mIBG, a sympathetic neurotransmitter radionuclide analog, aids in the detection of sympathetic innervation abnormalities and can be imaged with planar and single-photon emission computed tomographic techniques. Cardiac 123I-mIBG uptake can be assessed by the heart mediastinal ratio (H/M), tracer washout rate, and focal uptake defects. These parameters have been widely studied and shown to correlate strongly and independently with congestive heart failure progression, cardiac arrhythmias, cardiac death, and all-cause mortality. There is accumulating evidence that 123I-mIBG imaging can help to monitor a patient's clinical course and response to therapy. The ability to predict potentially lethal ventricular arrhythmias promises to help more accurately select patients for implantable cardioverter defibrillators, limiting unnecessary devices and identifying additional patients at risk who do not meet current guidelines. 123I-mIBG shows potential to help determine whether greater risk and usually more expensive ventricular assist device therapies or cardiac transplantation might be needed. Although more investigation in larger populations is needed to strengthen previous findings, cardiac 123I-mIBG imaging shows promise as a new technique for recognizing and following potentially life-threatening cardiac conditions.

UR - http://www.scopus.com/inward/record.url?scp=79960923863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960923863&partnerID=8YFLogxK

U2 - 10.1053/j.semnuclmed.2011.04.001

DO - 10.1053/j.semnuclmed.2011.04.001

M3 - Article

C2 - 21803188

AN - SCOPUS:79960923863

VL - 41

SP - 374

EP - 387

JO - Seminars in Nuclear Medicine

JF - Seminars in Nuclear Medicine

SN - 0001-2998

IS - 5

ER -